Europe and Switzerland to share confidential information on swine flu medicines
This article was originally published in Scrip
The European Medicines Agency (EMA) and Switzerland's regulator, Swissmedic, are to exchange confidential information on pandemic H1N1 medicines. The agreement follows Switzerland's request for more co-operation between the two agencies.
You may also be interested in...
Pharmaceutical industry groups say the European Commission’s Pharmaceutical Strategy Roadmap lacks detail on delivering a faster regulatory process and encouraging competitiveness.
The Australian Therapeutic Goods Administration is consulting on a draft standard for data matrix codes on the labels of certain medicines.
The European Medicines Agency received more requests for scientific advice in 2019 than it did in 2018. Meanwhile, requests for advice in other areas has fallen.